nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketorolac—PTGS1—Ifosfamide—testicular cancer	0.256	0.382	CbGbCtD
Ketorolac—PTGS2—Cisplatin—testicular cancer	0.147	0.22	CbGbCtD
Ketorolac—PTGS2—Etoposide—testicular cancer	0.145	0.216	CbGbCtD
Ketorolac—PTGS1—Etoposide—testicular cancer	0.122	0.182	CbGbCtD
Ketorolac—Hepatitis—Epirubicin—testicular cancer	0.00017	0.000515	CcSEcCtD
Ketorolac—Eye disorder—Methotrexate—testicular cancer	0.00017	0.000515	CcSEcCtD
Ketorolac—Tinnitus—Methotrexate—testicular cancer	0.000169	0.000513	CcSEcCtD
Ketorolac—Asthenia—Cisplatin—testicular cancer	0.000169	0.000512	CcSEcCtD
Ketorolac—Cardiac disorder—Methotrexate—testicular cancer	0.000168	0.000511	CcSEcCtD
Ketorolac—Sweating—Doxorubicin—testicular cancer	0.000168	0.000509	CcSEcCtD
Ketorolac—Urinary tract disorder—Epirubicin—testicular cancer	0.000168	0.000509	CcSEcCtD
Ketorolac—Haematuria—Doxorubicin—testicular cancer	0.000167	0.000506	CcSEcCtD
Ketorolac—Connective tissue disorder—Epirubicin—testicular cancer	0.000167	0.000506	CcSEcCtD
Ketorolac—Urethral disorder—Epirubicin—testicular cancer	0.000166	0.000505	CcSEcCtD
Ketorolac—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000166	0.000502	CcSEcCtD
Ketorolac—Epistaxis—Doxorubicin—testicular cancer	0.000165	0.000501	CcSEcCtD
Ketorolac—Angiopathy—Methotrexate—testicular cancer	0.000165	0.0005	CcSEcCtD
Ketorolac—Immune system disorder—Methotrexate—testicular cancer	0.000164	0.000497	CcSEcCtD
Ketorolac—Visual impairment—Epirubicin—testicular cancer	0.000164	0.000497	CcSEcCtD
Ketorolac—Mediastinal disorder—Methotrexate—testicular cancer	0.000164	0.000496	CcSEcCtD
Ketorolac—Agranulocytosis—Doxorubicin—testicular cancer	0.000163	0.000496	CcSEcCtD
Ketorolac—Chills—Methotrexate—testicular cancer	0.000163	0.000494	CcSEcCtD
Ketorolac—Nausea—Ifosfamide—testicular cancer	0.000162	0.000491	CcSEcCtD
Ketorolac—Diarrhoea—Cisplatin—testicular cancer	0.000161	0.000488	CcSEcCtD
Ketorolac—Erythema multiforme—Epirubicin—testicular cancer	0.000161	0.000487	CcSEcCtD
Ketorolac—Alopecia—Methotrexate—testicular cancer	0.00016	0.000487	CcSEcCtD
Ketorolac—Bradycardia—Doxorubicin—testicular cancer	0.00016	0.000485	CcSEcCtD
Ketorolac—Mental disorder—Methotrexate—testicular cancer	0.000159	0.000482	CcSEcCtD
Ketorolac—Eye disorder—Epirubicin—testicular cancer	0.000159	0.000482	CcSEcCtD
Ketorolac—Hypersensitivity—Etoposide—testicular cancer	0.000159	0.000481	CcSEcCtD
Ketorolac—Tinnitus—Epirubicin—testicular cancer	0.000158	0.00048	CcSEcCtD
Ketorolac—Erythema—Methotrexate—testicular cancer	0.000158	0.000479	CcSEcCtD
Ketorolac—Malnutrition—Methotrexate—testicular cancer	0.000158	0.000479	CcSEcCtD
Ketorolac—Haemoglobin—Doxorubicin—testicular cancer	0.000158	0.000479	CcSEcCtD
Ketorolac—Cardiac disorder—Epirubicin—testicular cancer	0.000158	0.000478	CcSEcCtD
Ketorolac—Flushing—Epirubicin—testicular cancer	0.000158	0.000478	CcSEcCtD
Ketorolac—Rhinitis—Doxorubicin—testicular cancer	0.000158	0.000478	CcSEcCtD
Ketorolac—Haemorrhage—Doxorubicin—testicular cancer	0.000157	0.000477	CcSEcCtD
Ketorolac—Hepatitis—Doxorubicin—testicular cancer	0.000157	0.000477	CcSEcCtD
Ketorolac—Urinary tract disorder—Doxorubicin—testicular cancer	0.000155	0.000471	CcSEcCtD
Ketorolac—Dysgeusia—Methotrexate—testicular cancer	0.000155	0.000469	CcSEcCtD
Ketorolac—Asthenia—Etoposide—testicular cancer	0.000154	0.000469	CcSEcCtD
Ketorolac—Connective tissue disorder—Doxorubicin—testicular cancer	0.000154	0.000469	CcSEcCtD
Ketorolac—Angiopathy—Epirubicin—testicular cancer	0.000154	0.000468	CcSEcCtD
Ketorolac—Urethral disorder—Doxorubicin—testicular cancer	0.000154	0.000467	CcSEcCtD
Ketorolac—Immune system disorder—Epirubicin—testicular cancer	0.000153	0.000465	CcSEcCtD
Ketorolac—Mediastinal disorder—Epirubicin—testicular cancer	0.000153	0.000464	CcSEcCtD
Ketorolac—Back pain—Methotrexate—testicular cancer	0.000153	0.000464	CcSEcCtD
Ketorolac—Chills—Epirubicin—testicular cancer	0.000152	0.000462	CcSEcCtD
Ketorolac—Pruritus—Etoposide—testicular cancer	0.000152	0.000462	CcSEcCtD
Ketorolac—Arrhythmia—Epirubicin—testicular cancer	0.000152	0.00046	CcSEcCtD
Ketorolac—Visual impairment—Doxorubicin—testicular cancer	0.000151	0.00046	CcSEcCtD
Ketorolac—Alopecia—Epirubicin—testicular cancer	0.00015	0.000455	CcSEcCtD
Ketorolac—Vomiting—Cisplatin—testicular cancer	0.000149	0.000453	CcSEcCtD
Ketorolac—Vision blurred—Methotrexate—testicular cancer	0.000149	0.000452	CcSEcCtD
Ketorolac—Mental disorder—Epirubicin—testicular cancer	0.000149	0.000451	CcSEcCtD
Ketorolac—Erythema multiforme—Doxorubicin—testicular cancer	0.000149	0.000451	CcSEcCtD
Ketorolac—Rash—Cisplatin—testicular cancer	0.000148	0.00045	CcSEcCtD
Ketorolac—Dermatitis—Cisplatin—testicular cancer	0.000148	0.000449	CcSEcCtD
Ketorolac—Erythema—Epirubicin—testicular cancer	0.000148	0.000449	CcSEcCtD
Ketorolac—Malnutrition—Epirubicin—testicular cancer	0.000148	0.000449	CcSEcCtD
Ketorolac—Diarrhoea—Etoposide—testicular cancer	0.000147	0.000447	CcSEcCtD
Ketorolac—Eye disorder—Doxorubicin—testicular cancer	0.000147	0.000446	CcSEcCtD
Ketorolac—Ill-defined disorder—Methotrexate—testicular cancer	0.000147	0.000445	CcSEcCtD
Ketorolac—Tinnitus—Doxorubicin—testicular cancer	0.000147	0.000445	CcSEcCtD
Ketorolac—Anaemia—Methotrexate—testicular cancer	0.000146	0.000443	CcSEcCtD
Ketorolac—Cardiac disorder—Doxorubicin—testicular cancer	0.000146	0.000443	CcSEcCtD
Ketorolac—Flushing—Doxorubicin—testicular cancer	0.000146	0.000443	CcSEcCtD
Ketorolac—Flatulence—Epirubicin—testicular cancer	0.000146	0.000442	CcSEcCtD
Ketorolac—Tension—Epirubicin—testicular cancer	0.000145	0.00044	CcSEcCtD
Ketorolac—Dysgeusia—Epirubicin—testicular cancer	0.000145	0.000439	CcSEcCtD
Ketorolac—Nervousness—Epirubicin—testicular cancer	0.000144	0.000436	CcSEcCtD
Ketorolac—Back pain—Epirubicin—testicular cancer	0.000143	0.000434	CcSEcCtD
Ketorolac—Angiopathy—Doxorubicin—testicular cancer	0.000143	0.000433	CcSEcCtD
Ketorolac—Malaise—Methotrexate—testicular cancer	0.000142	0.000432	CcSEcCtD
Ketorolac—Dizziness—Etoposide—testicular cancer	0.000142	0.000432	CcSEcCtD
Ketorolac—Immune system disorder—Doxorubicin—testicular cancer	0.000142	0.000431	CcSEcCtD
Ketorolac—Vertigo—Methotrexate—testicular cancer	0.000142	0.000431	CcSEcCtD
Ketorolac—Mediastinal disorder—Doxorubicin—testicular cancer	0.000142	0.00043	CcSEcCtD
Ketorolac—Leukopenia—Methotrexate—testicular cancer	0.000141	0.000429	CcSEcCtD
Ketorolac—Chills—Doxorubicin—testicular cancer	0.000141	0.000428	CcSEcCtD
Ketorolac—Arrhythmia—Doxorubicin—testicular cancer	0.00014	0.000426	CcSEcCtD
Ketorolac—Nausea—Cisplatin—testicular cancer	0.00014	0.000423	CcSEcCtD
Ketorolac—Vision blurred—Epirubicin—testicular cancer	0.000139	0.000423	CcSEcCtD
Ketorolac—Alopecia—Doxorubicin—testicular cancer	0.000139	0.000421	CcSEcCtD
Ketorolac—Cough—Methotrexate—testicular cancer	0.000138	0.000418	CcSEcCtD
Ketorolac—Mental disorder—Doxorubicin—testicular cancer	0.000138	0.000418	CcSEcCtD
Ketorolac—Ill-defined disorder—Epirubicin—testicular cancer	0.000137	0.000416	CcSEcCtD
Ketorolac—Convulsion—Methotrexate—testicular cancer	0.000137	0.000415	CcSEcCtD
Ketorolac—Vomiting—Etoposide—testicular cancer	0.000137	0.000415	CcSEcCtD
Ketorolac—Erythema—Doxorubicin—testicular cancer	0.000137	0.000415	CcSEcCtD
Ketorolac—Malnutrition—Doxorubicin—testicular cancer	0.000137	0.000415	CcSEcCtD
Ketorolac—Anaemia—Epirubicin—testicular cancer	0.000137	0.000415	CcSEcCtD
Ketorolac—Agitation—Epirubicin—testicular cancer	0.000136	0.000412	CcSEcCtD
Ketorolac—Rash—Etoposide—testicular cancer	0.000136	0.000412	CcSEcCtD
Ketorolac—Dermatitis—Etoposide—testicular cancer	0.000136	0.000411	CcSEcCtD
Ketorolac—Headache—Etoposide—testicular cancer	0.000135	0.000409	CcSEcCtD
Ketorolac—Flatulence—Doxorubicin—testicular cancer	0.000135	0.000409	CcSEcCtD
Ketorolac—Arthralgia—Methotrexate—testicular cancer	0.000135	0.000408	CcSEcCtD
Ketorolac—Myalgia—Methotrexate—testicular cancer	0.000135	0.000408	CcSEcCtD
Ketorolac—Chest pain—Methotrexate—testicular cancer	0.000135	0.000408	CcSEcCtD
Ketorolac—Tension—Doxorubicin—testicular cancer	0.000134	0.000407	CcSEcCtD
Ketorolac—Dysgeusia—Doxorubicin—testicular cancer	0.000134	0.000406	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000134	0.000405	CcSEcCtD
Ketorolac—Malaise—Epirubicin—testicular cancer	0.000133	0.000405	CcSEcCtD
Ketorolac—Discomfort—Methotrexate—testicular cancer	0.000133	0.000403	CcSEcCtD
Ketorolac—Nervousness—Doxorubicin—testicular cancer	0.000133	0.000403	CcSEcCtD
Ketorolac—Vertigo—Epirubicin—testicular cancer	0.000133	0.000403	CcSEcCtD
Ketorolac—Syncope—Epirubicin—testicular cancer	0.000133	0.000402	CcSEcCtD
Ketorolac—Leukopenia—Epirubicin—testicular cancer	0.000132	0.000402	CcSEcCtD
Ketorolac—Back pain—Doxorubicin—testicular cancer	0.000132	0.000402	CcSEcCtD
Ketorolac—Palpitations—Epirubicin—testicular cancer	0.000131	0.000396	CcSEcCtD
Ketorolac—Confusional state—Methotrexate—testicular cancer	0.00013	0.000394	CcSEcCtD
Ketorolac—Loss of consciousness—Epirubicin—testicular cancer	0.00013	0.000394	CcSEcCtD
Ketorolac—Cough—Epirubicin—testicular cancer	0.000129	0.000391	CcSEcCtD
Ketorolac—Anaphylactic shock—Methotrexate—testicular cancer	0.000129	0.000391	CcSEcCtD
Ketorolac—Vision blurred—Doxorubicin—testicular cancer	0.000129	0.000391	CcSEcCtD
Ketorolac—Convulsion—Epirubicin—testicular cancer	0.000128	0.000389	CcSEcCtD
Ketorolac—Infection—Methotrexate—testicular cancer	0.000128	0.000389	CcSEcCtD
Ketorolac—Nausea—Etoposide—testicular cancer	0.000128	0.000388	CcSEcCtD
Ketorolac—Hypertension—Epirubicin—testicular cancer	0.000128	0.000387	CcSEcCtD
Ketorolac—Ill-defined disorder—Doxorubicin—testicular cancer	0.000127	0.000385	CcSEcCtD
Ketorolac—Nervous system disorder—Methotrexate—testicular cancer	0.000126	0.000384	CcSEcCtD
Ketorolac—Anaemia—Doxorubicin—testicular cancer	0.000126	0.000384	CcSEcCtD
Ketorolac—Thrombocytopenia—Methotrexate—testicular cancer	0.000126	0.000383	CcSEcCtD
Ketorolac—Arthralgia—Epirubicin—testicular cancer	0.000126	0.000382	CcSEcCtD
Ketorolac—Myalgia—Epirubicin—testicular cancer	0.000126	0.000382	CcSEcCtD
Ketorolac—Chest pain—Epirubicin—testicular cancer	0.000126	0.000382	CcSEcCtD
Ketorolac—Agitation—Doxorubicin—testicular cancer	0.000126	0.000381	CcSEcCtD
Ketorolac—Anxiety—Epirubicin—testicular cancer	0.000125	0.000381	CcSEcCtD
Ketorolac—Skin disorder—Methotrexate—testicular cancer	0.000125	0.00038	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000125	0.000379	CcSEcCtD
Ketorolac—Hyperhidrosis—Methotrexate—testicular cancer	0.000125	0.000378	CcSEcCtD
Ketorolac—Discomfort—Epirubicin—testicular cancer	0.000124	0.000377	CcSEcCtD
Ketorolac—Malaise—Doxorubicin—testicular cancer	0.000123	0.000374	CcSEcCtD
Ketorolac—Dry mouth—Epirubicin—testicular cancer	0.000123	0.000374	CcSEcCtD
Ketorolac—Vertigo—Doxorubicin—testicular cancer	0.000123	0.000373	CcSEcCtD
Ketorolac—Anorexia—Methotrexate—testicular cancer	0.000123	0.000373	CcSEcCtD
Ketorolac—Syncope—Doxorubicin—testicular cancer	0.000123	0.000372	CcSEcCtD
Ketorolac—Leukopenia—Doxorubicin—testicular cancer	0.000122	0.000372	CcSEcCtD
Ketorolac—Confusional state—Epirubicin—testicular cancer	0.000122	0.000369	CcSEcCtD
Ketorolac—Palpitations—Doxorubicin—testicular cancer	0.000121	0.000367	CcSEcCtD
Ketorolac—Anaphylactic shock—Epirubicin—testicular cancer	0.000121	0.000366	CcSEcCtD
Ketorolac—Oedema—Epirubicin—testicular cancer	0.000121	0.000366	CcSEcCtD
Ketorolac—Hypotension—Methotrexate—testicular cancer	0.00012	0.000366	CcSEcCtD
Ketorolac—Loss of consciousness—Doxorubicin—testicular cancer	0.00012	0.000365	CcSEcCtD
Ketorolac—Infection—Epirubicin—testicular cancer	0.00012	0.000364	CcSEcCtD
Ketorolac—Cough—Doxorubicin—testicular cancer	0.000119	0.000362	CcSEcCtD
Ketorolac—Shock—Epirubicin—testicular cancer	0.000119	0.00036	CcSEcCtD
Ketorolac—Convulsion—Doxorubicin—testicular cancer	0.000119	0.00036	CcSEcCtD
Ketorolac—Nervous system disorder—Epirubicin—testicular cancer	0.000118	0.000359	CcSEcCtD
Ketorolac—Thrombocytopenia—Epirubicin—testicular cancer	0.000118	0.000358	CcSEcCtD
Ketorolac—Hypertension—Doxorubicin—testicular cancer	0.000118	0.000358	CcSEcCtD
Ketorolac—Tachycardia—Epirubicin—testicular cancer	0.000118	0.000357	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000117	0.000356	CcSEcCtD
Ketorolac—Skin disorder—Epirubicin—testicular cancer	0.000117	0.000356	CcSEcCtD
Ketorolac—Hyperhidrosis—Epirubicin—testicular cancer	0.000117	0.000354	CcSEcCtD
Ketorolac—Insomnia—Methotrexate—testicular cancer	0.000117	0.000354	CcSEcCtD
Ketorolac—Myalgia—Doxorubicin—testicular cancer	0.000116	0.000353	CcSEcCtD
Ketorolac—Chest pain—Doxorubicin—testicular cancer	0.000116	0.000353	CcSEcCtD
Ketorolac—Arthralgia—Doxorubicin—testicular cancer	0.000116	0.000353	CcSEcCtD
Ketorolac—Anxiety—Doxorubicin—testicular cancer	0.000116	0.000352	CcSEcCtD
Ketorolac—Paraesthesia—Methotrexate—testicular cancer	0.000116	0.000351	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000116	0.000351	CcSEcCtD
Ketorolac—Discomfort—Doxorubicin—testicular cancer	0.000115	0.000349	CcSEcCtD
Ketorolac—Anorexia—Epirubicin—testicular cancer	0.000115	0.000349	CcSEcCtD
Ketorolac—Dyspnoea—Methotrexate—testicular cancer	0.000115	0.000349	CcSEcCtD
Ketorolac—Somnolence—Methotrexate—testicular cancer	0.000115	0.000348	CcSEcCtD
Ketorolac—Dry mouth—Doxorubicin—testicular cancer	0.000114	0.000346	CcSEcCtD
Ketorolac—Dyspepsia—Methotrexate—testicular cancer	0.000114	0.000344	CcSEcCtD
Ketorolac—Hypotension—Epirubicin—testicular cancer	0.000113	0.000342	CcSEcCtD
Ketorolac—Confusional state—Doxorubicin—testicular cancer	0.000113	0.000342	CcSEcCtD
Ketorolac—Decreased appetite—Methotrexate—testicular cancer	0.000112	0.00034	CcSEcCtD
Ketorolac—Anaphylactic shock—Doxorubicin—testicular cancer	0.000112	0.000339	CcSEcCtD
Ketorolac—Oedema—Doxorubicin—testicular cancer	0.000112	0.000339	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000111	0.000338	CcSEcCtD
Ketorolac—Fatigue—Methotrexate—testicular cancer	0.000111	0.000337	CcSEcCtD
Ketorolac—Infection—Doxorubicin—testicular cancer	0.000111	0.000337	CcSEcCtD
Ketorolac—Pain—Methotrexate—testicular cancer	0.00011	0.000335	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.00011	0.000334	CcSEcCtD
Ketorolac—Shock—Doxorubicin—testicular cancer	0.00011	0.000333	CcSEcCtD
Ketorolac—Nervous system disorder—Doxorubicin—testicular cancer	0.000109	0.000332	CcSEcCtD
Ketorolac—Thrombocytopenia—Doxorubicin—testicular cancer	0.000109	0.000332	CcSEcCtD
Ketorolac—Insomnia—Epirubicin—testicular cancer	0.000109	0.000331	CcSEcCtD
Ketorolac—Tachycardia—Doxorubicin—testicular cancer	0.000109	0.000331	CcSEcCtD
Ketorolac—Skin disorder—Doxorubicin—testicular cancer	0.000108	0.000329	CcSEcCtD
Ketorolac—Paraesthesia—Epirubicin—testicular cancer	0.000108	0.000329	CcSEcCtD
Ketorolac—Hyperhidrosis—Doxorubicin—testicular cancer	0.000108	0.000328	CcSEcCtD
Ketorolac—Dyspnoea—Epirubicin—testicular cancer	0.000108	0.000326	CcSEcCtD
Ketorolac—Somnolence—Epirubicin—testicular cancer	0.000107	0.000325	CcSEcCtD
Ketorolac—Anorexia—Doxorubicin—testicular cancer	0.000106	0.000323	CcSEcCtD
Ketorolac—Feeling abnormal—Methotrexate—testicular cancer	0.000106	0.000322	CcSEcCtD
Ketorolac—Dyspepsia—Epirubicin—testicular cancer	0.000106	0.000322	CcSEcCtD
Ketorolac—Gastrointestinal pain—Methotrexate—testicular cancer	0.000105	0.00032	CcSEcCtD
Ketorolac—Decreased appetite—Epirubicin—testicular cancer	0.000105	0.000318	CcSEcCtD
Ketorolac—Hypotension—Doxorubicin—testicular cancer	0.000104	0.000317	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000104	0.000316	CcSEcCtD
Ketorolac—Fatigue—Epirubicin—testicular cancer	0.000104	0.000316	CcSEcCtD
Ketorolac—Pain—Epirubicin—testicular cancer	0.000103	0.000313	CcSEcCtD
Ketorolac—Constipation—Epirubicin—testicular cancer	0.000103	0.000313	CcSEcCtD
Ketorolac—Urticaria—Methotrexate—testicular cancer	0.000102	0.000311	CcSEcCtD
Ketorolac—Abdominal pain—Methotrexate—testicular cancer	0.000102	0.000309	CcSEcCtD
Ketorolac—Body temperature increased—Methotrexate—testicular cancer	0.000102	0.000309	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000102	0.000309	CcSEcCtD
Ketorolac—Insomnia—Doxorubicin—testicular cancer	0.000101	0.000306	CcSEcCtD
Ketorolac—Paraesthesia—Doxorubicin—testicular cancer	0.0001	0.000304	CcSEcCtD
Ketorolac—Dyspnoea—Doxorubicin—testicular cancer	9.95e-05	0.000302	CcSEcCtD
Ketorolac—Feeling abnormal—Epirubicin—testicular cancer	9.94e-05	0.000302	CcSEcCtD
Ketorolac—Somnolence—Doxorubicin—testicular cancer	9.93e-05	0.000301	CcSEcCtD
Ketorolac—Gastrointestinal pain—Epirubicin—testicular cancer	9.87e-05	0.000299	CcSEcCtD
Ketorolac—Dyspepsia—Doxorubicin—testicular cancer	9.83e-05	0.000298	CcSEcCtD
Ketorolac—Decreased appetite—Doxorubicin—testicular cancer	9.71e-05	0.000294	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Doxorubicin—testicular cancer	9.64e-05	0.000292	CcSEcCtD
Ketorolac—Fatigue—Doxorubicin—testicular cancer	9.63e-05	0.000292	CcSEcCtD
Ketorolac—Urticaria—Epirubicin—testicular cancer	9.59e-05	0.000291	CcSEcCtD
Ketorolac—Pain—Doxorubicin—testicular cancer	9.55e-05	0.00029	CcSEcCtD
Ketorolac—Constipation—Doxorubicin—testicular cancer	9.55e-05	0.00029	CcSEcCtD
Ketorolac—Abdominal pain—Epirubicin—testicular cancer	9.54e-05	0.000289	CcSEcCtD
Ketorolac—Body temperature increased—Epirubicin—testicular cancer	9.54e-05	0.000289	CcSEcCtD
Ketorolac—Hypersensitivity—Methotrexate—testicular cancer	9.5e-05	0.000288	CcSEcCtD
Ketorolac—Asthenia—Methotrexate—testicular cancer	9.25e-05	0.000281	CcSEcCtD
Ketorolac—Feeling abnormal—Doxorubicin—testicular cancer	9.2e-05	0.000279	CcSEcCtD
Ketorolac—Gastrointestinal pain—Doxorubicin—testicular cancer	9.13e-05	0.000277	CcSEcCtD
Ketorolac—Pruritus—Methotrexate—testicular cancer	9.12e-05	0.000277	CcSEcCtD
Ketorolac—Hypersensitivity—Epirubicin—testicular cancer	8.89e-05	0.00027	CcSEcCtD
Ketorolac—Urticaria—Doxorubicin—testicular cancer	8.87e-05	0.000269	CcSEcCtD
Ketorolac—Abdominal pain—Doxorubicin—testicular cancer	8.83e-05	0.000268	CcSEcCtD
Ketorolac—Body temperature increased—Doxorubicin—testicular cancer	8.83e-05	0.000268	CcSEcCtD
Ketorolac—Diarrhoea—Methotrexate—testicular cancer	8.82e-05	0.000268	CcSEcCtD
Ketorolac—Asthenia—Epirubicin—testicular cancer	8.66e-05	0.000263	CcSEcCtD
Ketorolac—Pruritus—Epirubicin—testicular cancer	8.54e-05	0.000259	CcSEcCtD
Ketorolac—Dizziness—Methotrexate—testicular cancer	8.53e-05	0.000259	CcSEcCtD
Ketorolac—Diarrhoea—Epirubicin—testicular cancer	8.26e-05	0.000251	CcSEcCtD
Ketorolac—Hypersensitivity—Doxorubicin—testicular cancer	8.23e-05	0.00025	CcSEcCtD
Ketorolac—Vomiting—Methotrexate—testicular cancer	8.2e-05	0.000249	CcSEcCtD
Ketorolac—Rash—Methotrexate—testicular cancer	8.13e-05	0.000247	CcSEcCtD
Ketorolac—Dermatitis—Methotrexate—testicular cancer	8.12e-05	0.000246	CcSEcCtD
Ketorolac—Headache—Methotrexate—testicular cancer	8.08e-05	0.000245	CcSEcCtD
Ketorolac—Asthenia—Doxorubicin—testicular cancer	8.01e-05	0.000243	CcSEcCtD
Ketorolac—Dizziness—Epirubicin—testicular cancer	7.98e-05	0.000242	CcSEcCtD
Ketorolac—Pruritus—Doxorubicin—testicular cancer	7.9e-05	0.00024	CcSEcCtD
Ketorolac—Vomiting—Epirubicin—testicular cancer	7.67e-05	0.000233	CcSEcCtD
Ketorolac—Nausea—Methotrexate—testicular cancer	7.66e-05	0.000232	CcSEcCtD
Ketorolac—Diarrhoea—Doxorubicin—testicular cancer	7.64e-05	0.000232	CcSEcCtD
Ketorolac—Rash—Epirubicin—testicular cancer	7.61e-05	0.000231	CcSEcCtD
Ketorolac—Dermatitis—Epirubicin—testicular cancer	7.6e-05	0.000231	CcSEcCtD
Ketorolac—Headache—Epirubicin—testicular cancer	7.56e-05	0.000229	CcSEcCtD
Ketorolac—Dizziness—Doxorubicin—testicular cancer	7.38e-05	0.000224	CcSEcCtD
Ketorolac—Nausea—Epirubicin—testicular cancer	7.17e-05	0.000217	CcSEcCtD
Ketorolac—Vomiting—Doxorubicin—testicular cancer	7.1e-05	0.000215	CcSEcCtD
Ketorolac—Rash—Doxorubicin—testicular cancer	7.04e-05	0.000214	CcSEcCtD
Ketorolac—Dermatitis—Doxorubicin—testicular cancer	7.03e-05	0.000213	CcSEcCtD
Ketorolac—Headache—Doxorubicin—testicular cancer	6.99e-05	0.000212	CcSEcCtD
Ketorolac—Nausea—Doxorubicin—testicular cancer	6.63e-05	0.000201	CcSEcCtD
